Letter to the Editor
Regarding the impact of left ventricular size on response to cardiac resynchronization therapy

https://doi.org/10.1016/j.ahj.2012.01.001Get rights and content

Cited by (6)

  • A literature embedding model for cardiovascular disease prediction using risk factors, symptoms, and genotype information

    2023, Expert Systems with Applications
    Citation Excerpt :

    LONP1 is associated with left ventricular contractile dysfunction (Svaguša et al., 2020), which can lead to ventricular fibrillation. Although the role of MIR4660 has not been fully identified, some works (Anderson & Mohler, 2007; Santulli et al., 2012, 2014; Yang et al., 2007) have shown that miR-1 levels appear to be augmented in ventricular arrhythmias (Anderson & Mohler, 2007; Yang et al., 2007). HEBP1 is a biomarker of Alzheimer’s disease (Yagensky et al., n.d.), which increases the risk of atrial/ventricular diseases (Bardai et al., 2014; Martins et al., 2020).

  • Sympathetic nervous system signaling in heart failure and cardiac aging

    2015, Pathophysiology and Pharmacotherapy of Cardiovascular Disease
  • Atrial fibrillation and microRNAs

    2014, Frontiers in Physiology
View full text